263. Cerebrotendinous xanthomatosis Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 6 / Drugs : 11 - (DrugBank : 2) / Drug target genes : 2 - Drug target pathways : 4
Cerebrotendinous xanthomatosis and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 263 | Cerebrotendinous xanthomatosis | - |
| 310 | Congenital anomalies syndrome | 2.000 |
| 6 | Parkinson disease | 2.000 |
| 299 | Cystic fibrosis | 2.000 |
| 94 | Primary sclerosing cholangitis | 2.000 |
| 46 | Malignant rheumatoid arthritis | 2.000 |
| 67 | Polycystic kidney disease | 2.000 |
| 84 | Sarcoidosis | 2.000 |
| 96 | Crohn disease | 2.000 |
| 265 | Lipodystrophy | 2.000 |
| 93 | Primary biliary cholangitis | 2.000 |
| 97 | Ulcerative colitis | 2.000 |